Novel estrogen analogue as well as preparation method and application thereof
An estrogen and analog technology, applied in the field of new estrogen analogs, can solve the problem of not involving specific drug molecules for the treatment of azoospermia, and achieve the effect of good drug effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0034] The preparation steps of the novel estrogen analogs are as follows: Add the weighed arylamine compound 1, substituted acetylene 2 and metal catalyst M m x n , add the corresponding solvent, in the air atmosphere, stir the reaction at a temperature of 60-120°C for 1h-48h, cool to room temperature, add ethyl acetate to dilute, wash with saturated brine, dry the organic phase with anhydrous magnesium sulfate, column layer Analysis and isolation of estrogen analogue 3.
[0035] Wherein, the arylamine compound 1 is selected from one of the following:
[0036]
Embodiment 1
[0039] Synthesis of N-benzyl-4-methoxy-2-(1-phenylvinyl)aniline:
[0040]
[0041] Add raw material 1a (0.20mmol), MnI 2 (0.04mmol), 2h (0.4mmol) and toluene (2.0mL), stirred at 100°C for 24h, cooled to room temperature, diluted with ethyl acetate (5mL), washed with saturated brine (5mL), and the organic phase was washed with anhydrous Dried over magnesium sulfate, spin-dried and then column chromatographed with eluent (ethyl acetate:n-hexane=1:100), the product 3h was obtained as 40 mg of white solid, with a yield of 63%. 1 H NMR (400MHz, CDCl 3 ): δ7.39–7.28(m,5H), 7.23–7.17(m,3H), 7.05–7.01(m,2H), 6.80–6.76(m,2H), 6.58(d,J=8.4Hz,1H ), 5.79(d, J=1.2Hz, 1H), 5.36(d, J=1.2Hz, 1H), 4.16(s, 2H), 3.77(s, 1H), 3.74(s, 3H); 13 C NMR (100MHz, CDCl 3 ): δ151.6, 147.0, 139.6, 139.6, 139.6, 128.7, 128.6, 128.4, 128.2, 127.2, 126.9, 126.7, 116.8, 116.5, 114.1, 112.2, 55.8, 48.9.
Embodiment 2
[0043] Synthesis of N-benzyl-2-(1-(2-fluorophenyl)vinyl)-4-methoxyaniline:
[0044]
[0045] Add raw material 1a (0.20mmol), MnCl 2 (0.02mmol), 2i (0.4mmol) and toluene (2.0mL), stirred at 100°C for 24h, cooled to room temperature, diluted with ethyl acetate (5mL), washed with saturated brine (5mL), and the organic phase was washed with anhydrous Dried over magnesium sulfate, spin-dried and then column chromatographed with eluent (ethyl acetate:n-hexane=1:100), the product 3i was obtained as 48 mg of white solid, with a yield of 72%. 1 H NMR (400MHz, CDCl 3 ): δ7.30–7.02(m,9H), 6.79–6.71(m,2H), 6.56(d,J=8.8Hz,1H), 5.87(t,J=1.2Hz,1H), 5.63(t, J=1.2Hz, 1H), 4.21(s, 2H), 3.94(s, 1H), 3.73(s, 3H); 13 C NMR (100MHz, CDCl 3): δ161.7, 159.2, 151.5, 141.4, 139.6, 139.3, 130.5(d, JC-F=3.1Hz), 129.3(d, JC-F=8.4Hz), 129.0, 128.5, 127.1, 127.0, 124.1(d, JC-F=3.7Hz), 121.4(d, JC-F=6.9Hz), 116.4, 116.3, 116.0, 113.9, 112.2, 55.8, 48.9; HRMS(ESI) m / z Calcd for C 22 h 20 FNO[M+H] +...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com